LLY Archives - VectorVest CA

8 08, 2024

Eli Lilly Climbs 8% on Impressive Earnings and Upbeat Outlook as Drug Sales Surge: Time to Buy?
Gallery
Eli Lilly Climbs 8% on Impressive Earnings and Upbeat Outlook as Drug Sales Surge: Time to Buy?

Feature: Stock Market Investing, Featured: News, Stock Market News

Eli Lilly Climbs 8% on Impressive Earnings and Upbeat Outlook as Drug Sales Surge: Time to Buy?

By VectorVest|2024-08-08T16:19:27+00:00August 8th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: Drug Manufacturers—General, earnings, Eli Lilly & Company, Featured, Healthcare, Hold Recommendation, LLY, Stocks In the News|

Eli Lilly & Co. (LLY) is up more than 8% so far Thursday morning after reporting second-quarter earnings that easily surpassed the Wall Street consensus. The company also raised its guidance for the full year. The drugmaker posted adjusted earnings per share of $3.92, well ahead of the $2.60 that was expected by analysts. [...]

26 06, 2023

Eli Lilly is Up 38% in the Past 3 Months: What Keeps Pushing the Stock Higher, and Will it Continue?
Gallery
Eli Lilly is Up 38% in the Past 3 Months: What Keeps Pushing the Stock Higher, and Will it Continue?

Feature: Stock Market Investing, Featured: News, Stock Market News

Eli Lilly is Up 38% in the Past 3 Months: What Keeps Pushing the Stock Higher, and Will it Continue?

By VectorVest|2023-06-26T20:06:22+00:00June 26th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: Drug Manufacturers—General, Eli Lilly, Healthcare, LLY|

While much of the recent focus within the stock market has been placed on the AI trend, one stock in the pharmaceutical industry has been on a surge so far this year: Eli Lilly (LLY). The stock sat at just $311/share at the start of March. And today, the stock sits at $452/share. But, [...]